Clever Culture Systems Reaffirms FY27 Sales Outlook As Pharma Orders Build
CC5: $0.016 +14.29% · MC: $36M
Clever Culture Systems says first-half FY27 sales and new evaluations are expected to reach eight APAS instruments, matching its full-year FY26 pharmaceutical placements; six are completed, with two more expected by year-end, including an order from a new top-20 pharmaceutical company. The company also reiterated plans for APAS Revolution, targeting a market it estimates is around 50% larger, with customer evaluations expected in 2027 and launch in the first half of 2028.

Comments